Transcriptomic Insights into the Response of the Olfactory Bulb to Selenium Treatment in a Mouse Model of Alzheimer's Disease

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2019 Jun 29

PMID 31248178

Citations 11

Authors

Rui Zheng

Zhong-Hao Zhang

Yu-Xi Zhao

Chen Chen

Shi-Zheng Jia

Xian-Chun Cao

Li-Ming Shen

Jia-Zuan Ni

Guo-Li Song

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by the presence of extracellular senile plaques primarily composed of Aβ peptides and intracellular neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau proteins. Olfactory dysfunction is an early clinical phenotype in AD and was reported to be attributable to the presence of NFTs, senile Aβ plaques in the olfactory bulb (OB). Our previous research found that selenomethionine (Se-Met), a major form of selenium (Se) in organisms, effectively increased oxidation resistance as well as reduced the generation and deposition of Aβ and tau hyperphosphorylation in the olfactory bulb of a triple transgenic mouse model of AD (3×Tg-AD), thereby suggesting a potential therapeutic option for AD. In this study, we further investigated changes in the transcriptome data of olfactory bulb tissues of 7-month-old triple transgenic AD (3×Tg-AD) mice treated with Se-Met (6 µg/mL) for three months. Comparison of the gene expression profile between Se-Met-treated and control mice revealed 143 differentially expressed genes (DEGs). Among these genes, 21 DEGs were upregulated and 122 downregulated. The DEGs were then annotated against the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. The results show that upregulated genes can be roughly classified into three types. Some of them mainly regulate the regeneration of nerves, such as , and ; some are involved in improving cognition and memory, such as ; and some are involved in anti-oxidative stress and anti-apoptosis, such as and . The downregulated genes are mainly associated with inflammation and apoptosis, such as , and . The reliability of the transcriptomic data was validated by quantitative real time polymerase chain reaction (qRT-PCR) for the selected genes. These results were in line with our previous study, which indicated therapeutic effects of Se-Met on AD mice, providing a theoretical basis for further study of the treatment of AD by Se-Met.

Citing Articles

TMF Attenuates Cognitive Impairment and Neuroinflammation by Inhibiting the MAPK/NF-κB Pathway in Alzheimer's Disease: A Multi-Omics Analysis.

Liu Y, Xu X, Wu X, Yang G, Luo J, Liang X Mar Drugs. 2025; 23(2).

PMID: 39997198 PMC: 11857128. DOI: 10.3390/md23020074.

Identification of sepsis-associated encephalopathy biomarkers through machine learning and bioinformatics approaches.

Lei J, Zhai J, Qi J, Sun C Sci Rep. 2024; 14(1):31717.

PMID: 39738412 PMC: 11685593. DOI: 10.1038/s41598-024-82885-8.

Selenium metabolism and selenoproteins function in brain and encephalopathy.

Li N, Zhang Z, Shen L, Song G, Tian J, Liu Q Sci China Life Sci. 2024; 68(3):628-656.

PMID: 39546178 DOI: 10.1007/s11427-023-2621-7.

The Role of Gut Microbiota in the Neuroprotective Effects of Selenium in Alzheimer's Disease.

Skalny A, Aschner M, Santamaria A, Filippini T, Gritsenko V, Tizabi Y Mol Neurobiol. 2024; 62(2):1675-1692.

PMID: 39012446 DOI: 10.1007/s12035-024-04343-w.

[High expression of secretogranin II increases oxaliplatin resistance of colorectal cancer cells].

Deng J, Pan T, Zhou G, Gao Y, Peng W, Wei W Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(10):1657-1664.

PMID: 37933640 PMC: 10630195. DOI: 10.12122/j.issn.1673-4254.2023.10.02.

References

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

Wirths O, Breyhan H, Marcello A, Cotel M, Bruck W, Bayer T . Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease. Neurobiol Aging. 2008; 31(5):747-57. DOI: 10.1016/j.neurobiolaging.2008.06.011. View

Jevtic S, Sengar A, Salter M, McLaurin J . The role of the immune system in Alzheimer disease: Etiology and treatment. Ageing Res Rev. 2017; 40:84-94. DOI: 10.1016/j.arr.2017.08.005. View

Marciniuk K, Taschuk R, Napper S . Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy. Clin Dev Immunol. 2013; 2013:473706. PMC: 3817797. DOI: 10.1155/2013/473706. View

Nieweg K, Schaller H, Pfrieger F . Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J Neurochem. 2009; 109(1):125-34. DOI: 10.1111/j.1471-4159.2009.05917.x. View

Huttenrauch M, Baches S, Gerth J, Bayer T, Weggen S, Wirths O . Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease. J Alzheimers Dis. 2014; 44(4):1291-302. DOI: 10.3233/JAD-142463. View

Zheng R, Zhang Z, Chen C, Chen Y, Jia S, Liu Q . Selenomethionine promoted hippocampal neurogenesis via the PI3K-Akt-GSK3β-Wnt pathway in a mouse model of Alzheimer's disease. Biochem Biophys Res Commun. 2017; 485(1):6-15. DOI: 10.1016/j.bbrc.2017.01.069. View

Zhang Z, Wu Q, Zheng R, Chen C, Chen Y, Liu Q . Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model. J Neurosci. 2017; 37(9):2449-2462. PMC: 6596838. DOI: 10.1523/JNEUROSCI.3229-16.2017. View

Wang C, Shou Y, Pan J, Du Y, Liu C, Wang H . The relationship between cholesterol level and Alzheimer's disease-associated APP proteolysis/Aβ metabolism. Nutr Neurosci. 2018; 22(7):453-463. DOI: 10.1080/1028415X.2017.1416942. View

10.

Oddo S, Caccamo A, Kitazawa M, Tseng B, LaFerla F . Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging. 2003; 24(8):1063-70. DOI: 10.1016/j.neurobiolaging.2003.08.012. View

11.

Young J, Heinbockel T, Gondre-Lewis M . Astrocyte fatty acid binding protein-7 is a marker for neurogenic niches in the rat hippocampus. Hippocampus. 2013; 23(12):1476-83. PMC: 3859315. DOI: 10.1002/hipo.22200. View

12.

Koster K, Thomas R, Morris A, Tai L . Epidermal growth factor prevents oligomeric amyloid-β induced angiogenesis deficits in vitro. J Cereb Blood Flow Metab. 2016; 36(11):1865-1871. PMC: 5094316. DOI: 10.1177/0271678X16669956. View

13.

Thomas R, Zuchowska P, Morris A, Marottoli F, Sunny S, Deaton R . Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice. Acta Neuropathol Commun. 2016; 4(1):111. PMC: 5084423. DOI: 10.1186/s40478-016-0387-3. View

14.

Pintana H, Apaijai N, Kerdphoo S, Pratchayasakul W, Sripetchwandee J, Suntornsaratoon P . Hyperglycemia induced the Alzheimer's proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats. Neurosci Lett. 2017; 655:41-45. DOI: 10.1016/j.neulet.2017.06.041. View

15.

Zhang Z, Wu Q, Chen C, Zheng R, Chen Y, Ni J . Comparison of the effects of selenomethionine and selenium-enriched yeast in the triple-transgenic mouse model of Alzheimer's disease. Food Funct. 2018; 9(7):3965-3973. DOI: 10.1039/c7fo02063e. View

16.

Willis M, Prokesch M, Hutter-Paier B, Windisch M, Stridsberg M, Mahata S . Chromogranin B and Secretogranin II in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations and in Alzheimer patients. J Alzheimers Dis. 2008; 13(2):123-35. DOI: 10.3233/jad-2008-13202. View

17.

Venditti P, Masullo P, Di Meo S, Agnisola C . Effects of prolonged aerobic exercise on myocardial responses to ischaemia-reperfusion in the rat. Exp Physiol. 2001; 86(3):341-8. DOI: 10.1113/eph8602175. View

18.

Manuel I, Lombardero L, LaFerla F, Gimenez-Llort L, Rodriguez-Puertas R . Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease. Neuroscience. 2016; 329:284-93. DOI: 10.1016/j.neuroscience.2016.05.012. View

19.

Matsumata M, Inada H, Osumi N . Fatty acid binding proteins and the nervous system: Their impact on mental conditions. Neurosci Res. 2014; 102:47-55. DOI: 10.1016/j.neures.2014.08.012. View

20.

Beart P . Synaptic signalling and its interface with neuropathologies: snapshots from the past, present and future. J Neurochem. 2016; 139 Suppl 2:76-90. DOI: 10.1111/jnc.13598. View